2371 - 2380 of 7915 Results
Title
Year
- Tandem Ring Opening/Intramolecular [2 + 2] Cycloaddition Reaction for the Synthesis of Cyclobutane Fused Thiazolino-2-Pyridones2021OPENTitle: Tandem Ring Opening/Intramolecular [2 + 2] Cycloaddition Reaction for the Synthesis of Cyclobutane Fused Thiazolino-2-PyridonesJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 86Issue #: 23Start Page: 16582End Page: 16592Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.joc.1c01875Best OA location URL: https://umu.diva-portal.org/smash/get/diva2:1612375/FULLTEXT02Citation Count: 2
- The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models2021OPENTitle: The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 11Issue #: 11Start Page: 1685End Page: 1685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom11111685Best OA location URL: https://www.mdpi.com/2218-273X/11/11/1685/pdf?version=1636779345Citation Count: 5
- Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation Carriers2021OPENTitle: Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation CarriersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 629End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940604Citation Count: 7
- Differential Effects of Pathological Beta Burst Dynamics Between Parkinson’s Disease Phenotypes Across Different Movements2021OPENTitle: Differential Effects of Pathological Beta Burst Dynamics Between Parkinson’s Disease Phenotypes Across Different MovementsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.733203Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.733203/pdfCitation Count: 22
- Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients2021OPENTitle: Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease PatientsJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.763777Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2021.763777/pdfCitation Count: 10
- The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells2021OPENTitle: The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cellsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 11Start Page: e0259903End Page: e0259903Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0259903Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0259903&type=printableCitation Count: 13
-
RESTRICTEDTitle: Glycosphingolipid metabolism and its role in ageing and Parkinson’s diseaseJournal Name: Glycoconjugate JournalPublisher: Springer Science and Business Media LLCVol: 39Issue #: 1Start Page: 39End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s10719-021-10023-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s10719-021-10023-x.pdfCitation Count: 19
-
OPENTitle: Impact of increased APP gene dose in Down syndrome and the Dp16 mouse modelJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 6Start Page: 1203End Page: 1234Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12463Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085977Citation Count: 31
-
OPENTitle: Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 23Start Page: 4465End Page: 4474Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00641Best OA location URL: https://doi.org/10.1021/acschemneuro.1c00641Citation Count: 16
- Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity2021OPENTitle: Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicityJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 3Issue #: 1Start Page: 96End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1cb00103eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2022/cb/d1cb00103eCitation Count: 8